Schistosoma mansoni triose phosphate isomerase peptide MAP4 is able to trigger naïve donor immune response towards a type-1 cytokine profile

Scandinavian Journal of Immunology

Volumn 68, Issue 2, 2008, Pages 169-176

  Reis, E A G ^a   Mauadi Carmo, T A ^a   Athanazio, R ^a   Reis, M G ^a,b   Harn Jr , D A ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD45RO ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN MAP 4; TRIOSEPHOSPHATE ISOMERASE;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHISTOSOMA MANSONI; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIGENS, HELMINTH; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; PEPTIDES; SCHISTOSOMA MANSONI; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TRIOSE-PHOSPHATE ISOMERASE;

EID: 47149102882     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02131.x     Document Type: Article

References (36)

1. McCullough KC, Summerfield A. Basic concepts of immune response and defense development. Ilar J 2005 46 : 230 40.
2. Mellman I. Antigen processing and presentation by dendritic cells: cell biological mechanisms. Adv Exp Med Biol 2005 560 : 63 7.
3. Inaba K, Inaba M. Antigen recognition and presentation by dendritic cells. Int J Hematol 2005 81 : 181 7.
4. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991 9 : 271 96.
5. Shankar AH, Titus RG. The influence of antigen-presenting cell type and interferon-gamma on priming and cytokine secretion of Leishmania major-specific T cells. J Infect Dis 1997 175 : 151 7.
6. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 1993 151 : 6742 50.
7. Ingulli E, Mondino A, Khoruts A, Jenkins MK. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med 1997 185 : 2133 41.
8. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995 182 : 389 400.
9. Majewska M, Szczepanik M. The role of Toll-like receptors (TLR) in innate and adaptive immune responses and their function in immune response regulation. Postepy Hig Med Dosw (Online) 2006 60 : 52 63.
10. Kronin V, Wu L, Gong S, Nussenzweig MC, Shortman K. DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses. Int Immunol 2000 12 : 731 5.
11. Dubey C, Croft M, Swain SL. Costimulatory requirements of naive CD4+ T cells ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response. J Immunol 1995 155 : 45 57.
12. Chang CC, Wright A, Punnonen J. Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J Immunol 2000 165 : 3584 91.
13. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000 18 : 593 620.
14. Rutitzky LI, Hernandez HJ, Stadecker MJ. Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc Natl Acad Sci U S A 2001 98 : 13243 8.
15. Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000 77 : 41 51.
16. Bergquist NR, Leonardo LR, Mitchell GF. Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 2005 21 : 112 7.
17. Harn DA, Mitsuyama M, Huguenel ED, Oligino L, David JR. Identification by monoclonal antibody of a major (28 kDa) surface membrane antigen of Schistosoma mansoni. Mol Biochem Parasitol 1985 16 : 345 54.
18. Zhu Y, Ren J, Da'dara A et al. The protective effect of a Schistosoma japonicum Chinese strain 23 kDa plasmid DNA vaccine in pigs is enhanced with IL-12. Vaccine 2004 23 : 78 83.
19. Reynolds SR, Dahl CE, Harn DA. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol 1994 152 : 193 200.
20. La Flamme AC, Patton EA, Pearce EJ. Role of gamma interferon in the pathogenesis of severe schistosomiasis in interleukin-4-deficient mice. Infect Immun 2001 69 : 7445 52.
21. Henri S, Chevillard C, Mergani A et al. Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 2002 169 : 929 36.
22. Katz N, Chaves A, Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1972 14 : 397 400.
23. Harn DA, Mitsuyama M, David JR. Schistosoma mansoni Anti-egg monoclonal antibodies protect against cercarial challenge in vivo. J Exp Med 1984 159 : 1371 87.
24. Harn DA, Danko K, Quinn JJ, Stadecker MJ. Schistosoma mansoni; the host immune response to egg antigens I. Partial characterization of cellular and humoral responses to pI fractions of soluble egg antigens. J Immunol 1989 142 : 2061 6.
25. Reis EA, Azevedo TM, McBride AJ, Harn DA Jr, Reis MG. Naive donor responses to Schistosoma mansoni soluble egg antigens. Scand J Immunol 2007 66 : 662 70.
26. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol 2005 175 : 5 14.
27. Abath FG, Morais CN, Montenegro CE, Wynn TA, Montenegro SM. Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 2006 22 : 85 91.
28. Ribeiro de Jesus A, Araujo I, Bacellar O et al. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect Immun 2000 68 : 2797 803.
29. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, Olds R. In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 2003 88 : 117 30.
30. Subramanian G, Kazura JW, Pearlman E, Jia X, Malhotra I, King CL. B7-2 requirement for helminth-induced granuloma formation and CD4 type 2 T helper cell cytokine expression. J Immunol 1997 158 : 5914 20.
31. Kelleher P, Knight SC. IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells. Int Immunol 1998 10 : 749 55.
32. Janeway CA, Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
33. Velupillai P, dos Reis EA, dos Reis MG, Harn DA. Lewis(x)-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis. Hum Immunol 2000 61 : 225 32.
34. Rutitzky LI, Ozkaynak E, Rottman JB, Stadecker MJ. Disruption of the ICOS-B7RP-1 costimulatory pathway leads to enhanced hepatic immunopathology and increased gamma interferon production by CD4 T cells in murine schistosomiasis. Infect Immun 2003 71 : 4040 4.
35. Vella AT, Pearce EJ. CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J Immunol 1992 148 : 2283 90.
36. Cox JH, Ivanyi J, Young DB, Lamb JR, Syred AD, Francis MJ. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur J Immunol 1988 18 : 2015 9.